HomeWorldTrump administration begins mass layoffs at health agencies: Report

Trump administration begins mass layoffs at health agencies: Report

The cuts, which also affect the National Institutes of Health, are part of a broad plan by President Trump and billionaire ally Elon Musk to shrink staffing levels in federal departments and agencies

April 01, 2025 / 20:29 IST
Story continues below Advertisement
Employees of the Department of Health and Human Services (HHS) hug each other as they queue outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration fired staff at the Centers for Disease Control and Prevention and at the Food and Drug Administration, as it embarked on its plan to cut 10,000 jobs at HHS, in Washington, D.C., U.S., April 1, 2025. REUTERS/Kevin Lamarque
Employees of the Department of Health and Human Services (HHS) hug each other as they queue outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration fired staff at the Centers for Disease Control and Prevention and at the Food and Drug Administration, as it embarked on its plan to cut 10,000 jobs at HHS, in Washington, D.C., U.S., April 1, 2025. REUTERS/Kevin Lamarque

The Trump administration has begun firing staff at major U.S. health agencies including the CDC and FDA as part of its plan to cut 10,000 government health jobs, sources familiar with the situation and a health official said on Tuesday.

The cuts, which also affect the National Institutes of Health, are part of a broad plan by President Donald Trump and billionaire ally Elon Musk to shrink staffing levels in federal departments and agencies.

Story continues below Advertisement

Health Secretary Robert F. Kennedy Jr. has described the cuts at the Centers for Disease Control and Prevention and the Food and Drug Administration as essential to streamlining a bloated bureaucracy. However the cuts - including earlier dismissals - have led to the departures of top scientists at key agencies for public health, cancer research and drug oversight, raising concerns about how the U.S. will safely oversee the health sector and respond to emergencies.

Peter Stein, the director of the Office of New Drugs in the FDA's Center for Drug Evaluation and Research division, resigned on Tuesday when faced with being fired, according to one source familiar with the matter.